Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Piroxicam

A non-steroidal anti-inflammatory drug of the oxicam class, born from a research project started in 1962, approved in 1979 and first marketed in 1980; it is used in chronic inflammatory joint diseases such as rheumatoid arthritis and osteoarthritis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?Its half-life is about 50 hours, one of the longest among anti-inflammatories: it stays in the body so long that its action is very long-lasting.

PiroxicamGo to the active ingredient →
PiroxicamActive ingredientPiroxicamCat. No. P-P138-001CAS 36322-90-4
Piroxicam-d3Isotopically labelledPiroxicam-d3Cat. No. P-P138-015CAS 942047-64-5

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Reference substancePiroxicam CRSEDQM code P2130000Family Piroxicam

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.